Tent France - the national business coalition committed to helping refugees connect to work across the country - is proud to announce 14 new member companies ...

Receiving a breast cancer diagnosis is a life-changing moment, and the journey through treatment can often feel overwhelming.

Receiving a breast cancer diagnosis is a life-changing moment, and the journey through treatment can often feel overwhelming. From managing ...

Tent France – the national business coalition committed to helping refugees connect to work across the country – is proud to ...

DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Switzerland market closed weak on Monday although the downside was much less pronounced than the losses posted by most of the ...

Novartis has reached an agreement to take control of Kate Therapeutics, a developer of gene therapies for inherited neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The ...

In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus alliance with UK biotech Artios Pharma to develop precision medicines for cancer.

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...